Cubans develop synthetic vaccines

Cuban researchers have produced the first synthetic vaccine against pneumonia and meningitis, press reports said on Saturday.

    Discovery may lead to the future of disease prevention

    Vicente Verez, head of the University of Havana's Antigen Research Center, told the Cuban press agency AIN the vaccine would be presented to a biotechnology congress in Havana from 23-28 November.

    He said the vaccine was designed to be administered to infants in three doses - at two, four and six months - with a booster at 18 months.

    Clinical studies done in Camaguay in central Cuba showed that more than 99% of babies vaccinated developed antibodies against the pneumonia and meningitis viruses as well as other diseases, he said.

    Synthetically produced vaccines offer many advantages over conventional vaccines, including enhanced purity and effectiveness. They also have a longer shelf life and can be mass produced, potentially at a lower cost.

    SOURCE: AFP


    YOU MIGHT ALSO LIKE

    The 'risky business' of tracking Rwandan fugitive Felicien Kabuga

    The 'risky business' of tracking Rwandan fugitive Felicien Kabuga

    The former chief prosecutor at the International Criminal Tribunal for Rwanda discusses the hunt for genocide suspects.

    Doctors race to understand new illness afflicting children

    Doctors race to understand new illness afflicting children

    More and more cases of a Kawasaki-like disease, called PMIS or MIS-C, reported among children exposed to coronavirus.

    Lockdown life in New Zealand, the bubble that 'beat' coronavirus

    Lockdown life in New Zealand, the bubble that 'beat' coronavirus

    What life in one neighbourhood says about New Zealand's bold, and seemingly successful, plan to eliminate COVID-19.